USD 18.68
(-2.66%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 7.37 Billion USD | -3.57% |
2022 | 7.64 Billion USD | -17.1% |
2021 | 9.22 Billion USD | -1.31% |
2020 | 9.34 Billion USD | 8.59% |
2019 | 8.6 Billion USD | -0.97% |
2018 | 8.68 Billion USD | -16.31% |
2017 | 10.37 Billion USD | -10.95% |
2016 | 11.65 Billion USD | 164.74% |
2015 | 4.4 Billion USD | -5.32% |
2014 | 4.65 Billion USD | -8.42% |
2013 | 5.07 Billion USD | 2.13% |
2012 | 4.97 Billion USD | 4.56% |
2011 | 4.75 Billion USD | 45.96% |
2010 | 3.25 Billion USD | 5.51% |
2009 | 3.08 Billion USD | 9.1% |
2008 | 2.83 Billion USD | 5.79% |
2007 | 2.67 Billion USD | 22.66% |
2006 | 2.18 Billion USD | -9.39% |
2005 | 2.4 Billion USD | -13.97% |
2004 | 2.79 Billion USD | 14.42% |
2003 | 2.44 Billion USD | 17.18% |
2002 | 2.08 Billion USD | 16.07% |
2001 | 1.79 Billion USD | 107.49% |
2000 | 866.61 Million USD | 0.82% |
1999 | 859.6 Million USD | -3.99% |
1998 | 895.3 Million USD | 15.61% |
1997 | 774.4 Million USD | 15.98% |
1996 | 667.7 Million USD | 11.71% |
1995 | 597.7 Million USD | 25.94% |
1994 | 474.6 Million USD | -5.95% |
1993 | 504.6 Million USD | 443.16% |
1992 | 92.9 Million USD | 20.03% |
1991 | 77.4 Million USD | 230.77% |
1990 | 23.4 Million USD | 69.57% |
1989 | 13.8 Million USD | 9.52% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 7.12 Billion USD | -3.35% |
2024 Q2 | 6.89 Billion USD | -3.17% |
2023 Q3 | 7.2 Billion USD | -5.87% |
2023 Q4 | 7.37 Billion USD | 2.35% |
2023 Q1 | 7.67 Billion USD | 0.39% |
2023 Q2 | 7.65 Billion USD | -0.3% |
2023 FY | 7.37 Billion USD | -3.57% |
2022 Q4 | 7.64 Billion USD | 1.61% |
2022 Q1 | 9.16 Billion USD | -0.65% |
2022 Q3 | 7.52 Billion USD | -15.94% |
2022 Q2 | 8.94 Billion USD | -2.31% |
2022 FY | 7.64 Billion USD | -17.1% |
2021 Q1 | 9.13 Billion USD | -2.19% |
2021 Q4 | 9.22 Billion USD | -0.73% |
2021 Q3 | 9.28 Billion USD | -0.96% |
2021 FY | 9.22 Billion USD | -1.31% |
2021 Q2 | 9.37 Billion USD | 2.64% |
2020 Q2 | 8.6 Billion USD | 6.77% |
2020 Q3 | 8.89 Billion USD | 3.39% |
2020 Q4 | 9.34 Billion USD | 5.01% |
2020 FY | 9.34 Billion USD | 8.59% |
2020 Q1 | 8.05 Billion USD | -6.33% |
2019 FY | 8.6 Billion USD | -0.97% |
2019 Q4 | 8.6 Billion USD | 2.82% |
2019 Q2 | 8.57 Billion USD | -0.34% |
2019 Q3 | 8.36 Billion USD | -2.43% |
2019 Q1 | 8.6 Billion USD | -0.95% |
2018 Q3 | 8.76 Billion USD | -0.6% |
2018 Q2 | 8.82 Billion USD | -14.95% |
2018 Q1 | 10.37 Billion USD | -0.07% |
2018 Q4 | 8.68 Billion USD | -0.94% |
2018 FY | 8.68 Billion USD | -16.31% |
2017 Q1 | 11.59 Billion USD | -0.53% |
2017 FY | 10.37 Billion USD | -10.95% |
2017 Q4 | 10.37 Billion USD | -7.31% |
2017 Q3 | 11.19 Billion USD | 3.22% |
2017 Q2 | 10.85 Billion USD | -6.42% |
2016 Q4 | 11.65 Billion USD | -2.48% |
2016 Q3 | 11.95 Billion USD | 4.38% |
2016 Q1 | 11.68 Billion USD | 165.33% |
2016 FY | 11.65 Billion USD | 164.74% |
2016 Q2 | 11.45 Billion USD | -1.98% |
2015 Q2 | 4.49 Billion USD | 2.55% |
2015 Q1 | 4.38 Billion USD | -5.71% |
2015 FY | 4.4 Billion USD | -5.32% |
2015 Q4 | 4.4 Billion USD | 0.02% |
2015 Q3 | 4.4 Billion USD | -2.1% |
2014 Q1 | 5.08 Billion USD | 0.22% |
2014 Q3 | 4.88 Billion USD | -3.71% |
2014 FY | 4.65 Billion USD | -8.42% |
2014 Q4 | 4.65 Billion USD | -4.79% |
2014 Q2 | 5.07 Billion USD | -0.34% |
2013 Q4 | 5.07 Billion USD | 1.36% |
2013 Q1 | 4.9 Billion USD | -1.41% |
2013 Q2 | 4.87 Billion USD | -0.56% |
2013 Q3 | 5 Billion USD | 2.78% |
2013 FY | 5.07 Billion USD | 2.13% |
2012 FY | 4.97 Billion USD | 4.56% |
2012 Q1 | 5.01 Billion USD | 5.46% |
2012 Q2 | 4.87 Billion USD | -2.88% |
2012 Q3 | 4.97 Billion USD | 2.19% |
2012 Q4 | 4.97 Billion USD | -0.1% |
2011 FY | 4.75 Billion USD | 45.96% |
2011 Q4 | 4.75 Billion USD | -1.62% |
2011 Q3 | 4.83 Billion USD | 32.19% |
2011 Q2 | 3.65 Billion USD | 6.39% |
2011 Q1 | 3.43 Billion USD | 5.5% |
2010 Q3 | 3.19 Billion USD | 14.22% |
2010 Q2 | 2.79 Billion USD | -6.34% |
2010 FY | 3.25 Billion USD | 5.51% |
2010 Q4 | 3.25 Billion USD | 1.97% |
2010 Q1 | 2.98 Billion USD | -3.28% |
2009 Q1 | 2.76 Billion USD | -2.46% |
2009 Q3 | 3.06 Billion USD | 5.82% |
2009 Q4 | 3.08 Billion USD | 0.68% |
2009 FY | 3.08 Billion USD | 9.1% |
2009 Q2 | 2.89 Billion USD | 4.99% |
2008 Q2 | 2.99 Billion USD | 2.68% |
2008 Q3 | 2.66 Billion USD | -11.09% |
2008 Q4 | 2.83 Billion USD | 6.35% |
2008 FY | 2.83 Billion USD | 5.79% |
2008 Q1 | 2.91 Billion USD | 8.95% |
2007 FY | 2.67 Billion USD | 22.66% |
2007 Q1 | 2.29 Billion USD | 5.2% |
2007 Q2 | 2.38 Billion USD | 4.09% |
2007 Q4 | 2.67 Billion USD | 2.32% |
2007 Q3 | 2.61 Billion USD | 9.48% |
2006 Q1 | 2.44 Billion USD | 1.45% |
2006 Q2 | 2.56 Billion USD | 5.1% |
2006 Q3 | 2.56 Billion USD | 0.01% |
2006 Q4 | 2.18 Billion USD | -15.02% |
2006 FY | 2.18 Billion USD | -9.39% |
2005 Q1 | 2.69 Billion USD | -3.64% |
2005 FY | 2.4 Billion USD | -13.97% |
2005 Q3 | 2.46 Billion USD | -4.14% |
2005 Q4 | 2.4 Billion USD | -2.37% |
2005 Q2 | 2.57 Billion USD | -4.6% |
2004 FY | 2.79 Billion USD | 14.42% |
2004 Q1 | 2.51 Billion USD | 2.85% |
2004 Q2 | 2.53 Billion USD | 0.79% |
2004 Q3 | 2.61 Billion USD | 3.27% |
2004 Q4 | 2.79 Billion USD | 6.88% |
2003 FY | 2.44 Billion USD | 17.18% |
2003 Q4 | 2.44 Billion USD | 4.85% |
2003 Q3 | 2.33 Billion USD | 1.22% |
2003 Q2 | 2.3 Billion USD | 5.27% |
2003 Q1 | 2.18 Billion USD | 4.88% |
2002 Q2 | 1.97 Billion USD | 8.5% |
2002 FY | 2.08 Billion USD | 16.07% |
2002 Q1 | 1.81 Billion USD | 1.01% |
2002 Q4 | 2.08 Billion USD | 4.56% |
2002 Q3 | 1.99 Billion USD | 1.29% |
2001 Q3 | 1.21 Billion USD | 4.85% |
2001 Q1 | 1.07 Billion USD | 24.14% |
2001 FY | 1.79 Billion USD | 107.49% |
2001 Q2 | 1.16 Billion USD | 8.09% |
2001 Q4 | 1.79 Billion USD | 47.49% |
2000 Q4 | 866.61 Million USD | 2.61% |
2000 Q2 | 851 Million USD | 0.88% |
2000 Q1 | 843.55 Million USD | -1.87% |
2000 FY | 866.61 Million USD | 0.82% |
2000 Q3 | 844.58 Million USD | -0.75% |
1999 FY | 859.6 Million USD | -3.99% |
1999 Q3 | 882.2 Million USD | 0.1% |
1999 Q4 | 859.6 Million USD | -2.56% |
1999 Q1 | 875.8 Million USD | -2.18% |
1999 Q2 | 881.3 Million USD | 0.63% |
1998 Q2 | 869.3 Million USD | 8.23% |
1998 Q4 | 895.3 Million USD | 0.65% |
1998 Q3 | 889.5 Million USD | 2.32% |
1998 Q1 | 803.2 Million USD | 3.72% |
1998 FY | 895.3 Million USD | 15.61% |
1997 FY | 774.4 Million USD | 15.98% |
1997 Q1 | 743.7 Million USD | 11.38% |
1997 Q2 | 740.1 Million USD | -0.48% |
1997 Q3 | 759.5 Million USD | 2.62% |
1997 Q4 | 774.4 Million USD | 1.96% |
1996 Q1 | 654.8 Million USD | 9.55% |
1996 FY | 667.7 Million USD | 11.71% |
1996 Q2 | 660.9 Million USD | 0.93% |
1996 Q3 | 665.9 Million USD | 0.76% |
1996 Q4 | 667.7 Million USD | 0.27% |
1995 Q3 | 579.8 Million USD | -2.65% |
1995 Q2 | 595.6 Million USD | 20.01% |
1995 FY | 597.7 Million USD | 25.94% |
1995 Q4 | 597.7 Million USD | 3.09% |
1995 Q1 | 496.3 Million USD | 4.57% |
1994 FY | 474.6 Million USD | -5.95% |
1994 Q1 | 492.9 Million USD | -2.32% |
1994 Q2 | 500.7 Million USD | 1.58% |
1994 Q3 | 498.5 Million USD | -0.44% |
1994 Q4 | 474.6 Million USD | -4.79% |
1993 Q3 | 499.2 Million USD | 2.65% |
1993 FY | 504.6 Million USD | 443.16% |
1993 Q1 | 128.8 Million USD | 3.79% |
1993 Q2 | 486.3 Million USD | 277.56% |
1993 Q4 | 504.6 Million USD | 1.08% |
1992 Q2 | 99.8 Million USD | 7.43% |
1992 Q3 | 118.6 Million USD | 18.84% |
1992 Q1 | 92.9 Million USD | 14.98% |
1992 FY | 92.9 Million USD | 20.03% |
1992 Q4 | 124.1 Million USD | 4.64% |
1991 Q2 | 76.8 Million USD | -0.78% |
1991 FY | 77.4 Million USD | 230.77% |
1991 Q3 | 71.7 Million USD | -6.64% |
1991 Q4 | 80.8 Million USD | 12.69% |
1991 Q1 | 77.4 Million USD | -2.15% |
1990 Q1 | 23.4 Million USD | -2.09% |
1990 FY | 23.4 Million USD | 69.57% |
1990 Q2 | 26.7 Million USD | 14.1% |
1990 Q3 | 79.4 Million USD | 197.38% |
1990 Q4 | 79.1 Million USD | -0.38% |
1989 Q1 | 13.8 Million USD | 0.0% |
1989 FY | 13.8 Million USD | 9.52% |
1989 Q3 | 23.8 Million USD | 2.59% |
1989 Q2 | 23.2 Million USD | 68.12% |
1989 Q4 | 23.9 Million USD | 0.42% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Akoya Biosciences, Inc. | 180.36 Million USD | -3986.068% |
AngioDynamics, Inc. | 317.67 Million USD | -2220.01% |
AtriCure, Inc. | 613.93 Million USD | -1100.459% |
Avinger, Inc. | 13.77 Million USD | -53422.15% |
Azenta, Inc. | 2.88 Billion USD | -155.396% |
BioLife Solutions, Inc. | 412.71 Million USD | -1685.74% |
The Cooper Companies, Inc. | 11.65 Billion USD | 36.786% |
Daxor Corporation | 34.86 Million USD | -21036.167% |
Ekso Bionics Holdings, Inc. | 28.91 Million USD | -25385.857% |
Femasys Inc. | 27.75 Million USD | -26452.985% |
GlucoTrack, Inc. | 4.9 Million USD | -150154.842% |
Harvard Bioscience, Inc. | 137.36 Million USD | -5265.229% |
Hologic, Inc. | 9.15 Billion USD | 19.506% |
ICU Medical, Inc. | 4.37 Billion USD | -68.325% |
Intuitive Surgical, Inc. | 15.44 Billion USD | 52.271% |
KORU Medical Systems, Inc. | 28.46 Million USD | -25795.11% |
LeMaitre Vascular, Inc. | 346.77 Million USD | -2025.279% |
Innovative Eyewear, Inc. | 6.21 Million USD | -118412.334% |
Innovative Eyewear, Inc. | 6.21 Million USD | -118412.334% |
Masimo Corporation | 3.04 Billion USD | -142.315% |
Microbot Medical Inc. | 8.32 Million USD | -88407.266% |
Meihua International Medical Technologies Co., Ltd. | 171.91 Million USD | -4186.996% |
Merit Medical Systems, Inc. | 2.32 Billion USD | -216.956% |
Nephros, Inc. | 11.86 Million USD | -62036.413% |
NovoCure Limited | 1.14 Billion USD | -543.034% |
NEXGEL, Inc. | 9.95 Million USD | -73933.149% |
NEXGEL, Inc. | 9.95 Million USD | -73933.149% |
Singular Genomics Systems, Inc. | 265.46 Million USD | -2676.24% |
OraSure Technologies, Inc. | 482.84 Million USD | -1426.37% |
Pro-Dex, Inc. | 54.21 Million USD | -13495.278% |
Pulse Biosciences, Inc. | 60.8 Million USD | -12020.913% |
Predictive Oncology Inc. | 14.41 Million USD | -51019.322% |
Precision Optics Corporation, Inc. | 16.91 Million USD | -43477.045% |
QuidelOrtho Corporation | 8.56 Billion USD | 13.933% |
Repligen Corporation | 2.82 Billion USD | -160.939% |
Sanara MedTech Inc. | 73.87 Million USD | -9876.831% |
STAAR Surgical Company | 488.69 Million USD | -1408.107% |
Sharps Technology, Inc. | 11.78 Million USD | -62414.484% |
Utah Medical Products, Inc. | 135.45 Million USD | -5340.801% |
Jin Medical International Ltd. | 32.9 Million USD | -22298.867% |